Colin Walsh is Director at Attovia Therapeutics, Inc. (ATTO). They have made 3 open-market trades across 1 company since 2026, most recently 2026-08-06.
CIK 0001866174
2 open-market purchases totalling $12.5M since 2026, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATTO | 105,807 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2026-08-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.